3D MoA on Dual Targeting of Cancer Glycans and Lipids
Project Goal
The goal of this project was to create a scientific animation that communicates Vitruviae’s dual targeting approach, highlighting the limitations of protein-only targeting and the advantages of targeting cancer-associated glycans and lipids. The animation introduces the broader platform and pipeline within a clear, unified narrative for scientific and investor audiences.
Cancer-Associated Glycans and Lipids vs Normal Cell Membrane
VTRU200 and VCAR300 in membrane
VTRU200 Guides Host Immune Cells to Cancer Cells
The Process
Animation type:
3D Animation
Project timline:
6 weeks
Review:
5 zoom calls + 4 e-mail feedback sessions
Team:
Find out which of our 26 scientific animation options works best for investor relations and communications:
Vitruviae required a scientific animation to communicate its differentiated targeting strategy and broader therapeutic platform for investor and scientific audiences. Our scientific team first analyzed the underlying biology of glycan- and lipid-based targeting before developing an initial script, which was refined in collaboration with the client prior to production. The process followed a structured pipeline—from storyboards to animatics to final renders—allowing the client to review key milestones while minimizing time demands.
To clearly illustrate both the limitations of protein-based targeting and Vitruviae’s dual targeting approach, we developed a visual system built around 3D compositions, molecular animation, and split-screen comparisons. Because the science spans multiple scales, the animation progresses from simplified cellular environments into molecular cut-ins, where scientifically accurate models—developed with input from our scientific team—represent glycans, lipids, and engineered therapeutic constructs. This unified visual language was extended across the full platform—VTRU100, VTRU200, VCAR300, and VRAD600—connecting targeting, immune engagement, and payload delivery within a consistent framework.
Outcome
The final animation provided Vitruviae with a clear and visually cohesive way to communicate its differentiated targeting strategy and broader therapeutic platform. By combining cellular context with molecular detail, the piece simplifies complex science into a narrative that is accessible to both scientific and investor audiences. The animation now serves as a core communication asset, supporting presentations, digital platforms, and medical communication solutions for biotech.
